地龙组分对UUO大鼠p38MAPK、NF-κB影响的研究
|
摘要
目的：通过动物实验观察地龙组分丝氨酸蛋白水解酶对单侧输尿管梗阻(UUO)大鼠p38MAPK信号通路及核转录因子κB的影响探讨地龙组分丝氨酸蛋白水解酶抗肾间质纤维化的作用机制
方法：采用大鼠单侧输尿管梗阻法复制肾间质纤维化模型。将健康雄性Wistar大鼠60只,随机分组：假手术组12只,模型组16只,地龙低剂量组16只,地龙高剂量组16只。地龙低剂量组给-予地龙组分丝氨酸蛋白水解酶胶囊0.24g·kg1-·d-1灌胃；地龙高剂量组给予地龙组分丝氨酸蛋白水解酶胶囊0.48g·kg-1·d-1灌胃；假手术组和模型组给等量蒸馏水灌胃。分别于术后第2W、4W处死各组的6只大鼠,处死前一天收集24h尿量检测24h尿蛋白定量,处死当天收集静脉血用于血清肌酐(Scr)、尿素氮(BUN)指标的检测。取梗阻侧肾组织标本,HE染色后光镜下观察肾脏病理改变；免疫组织化学方法检测肾组织中TGF-β1、a-SMA、Col-Ⅳ的表达；Western blot检测肾组织中NF-κB、p38MAPK的蛋白表达
结果：
(1)从外观上看,与模型组相比,地龙治疗组在对应时间点上梗阻侧肾脏的肿大及积水程度较轻,色泽较红润。
(2)在不同的时间点各组大鼠24h尿蛋白定量无统计学差异(P>0.05)。
(3)地龙治疗组大鼠的Scr、BUN水平在第2、4W时均低于模型组(p<0.05或p<0.01)；相同时间点,地龙低剂量组大鼠血清Scr、 BUN水平低于地龙高剂量组。
(4)免疫组化结果显示：模型组及地龙治疗组大鼠肾组织中TGF-β1、a-SMA、Col-Ⅳ的表达随梗阻时间的延长,逐渐增多；在对应的时间点,地龙高、低剂量组与模型组大鼠相比,TGF-β1、 a-SMA、Col-Ⅳ的蛋白表达显著降低(p<0.05或p<0.01)。
(5)Western blot结果显示：随着梗阻时间的延长,模型组及地龙治疗组NF-κB、p38MAPK的表达逐渐增多,地龙治疗组NF-κB、p38MAPK的表达明显低于对应时间点模型组(p<0.05)。
(6)实验观察到地龙低剂量组疗效优于高剂量组
结论：
(1)地龙组分能够降低UUO模型大鼠的血清Scr、BUN水平具有保护肾功能作用。
(2)地龙组分能够改变肾脏组织形态、减轻肾间质纤维化程度,具有减轻UUO大鼠肾组织损伤作用
(3)地龙组分可能是通过下调α-SMA和Col-Ⅳ的表达来抑制成纤维细胞过度活化,减少ECM的过度积聚,来延缓肾间质纤维化的进展
(4)地龙组分可能是通过多靶点阻断TGF-β1→p3MAPK→NF-κB信号传导通路,来实现其延缓肾间质纤维化进程的作用
Objective:
To investigate the effect of earthworm component serine hydrolase on p38mitogen-actived protein kinase signaling pathway and nuelear factork kappa B of unilateral ureteralobstruction rats.and to illustrate the mechanism of the components of earthworm serine hydrolase on delaying renal interstitial fibrosis.
Method:
Copy the model of renal interstitial fibrosis in rats with unilateral ureteral obstructi on.The60male wistar rats were randomly divided into four groups:sham-operation group(12),UUO group (16), earthworm of low-dose group (16),earth worm of high-dose group (16). Earthworm of low-dose group was given the earthworm component of serine proteolytic enzymes capsules0.24g·kg-1·d-1to gavage.Earthworm of high-dose group was given the earthworm component of serine proteolytic enzymes capsules0.48g·kg-1·d-1to gavage.Sham operation group and UUO group were given the same dose of distilled water.6rats of each group were killed respectively at the2,4weeks after surgery.Put to death the day after the collection of24h urine detection of24urinary protein excretion, executed the same day to collect blood for serum creatinine (Scr),blood urea nitrogen(BUN)index detection. Take the obstructed kidney tissue specimens.HE staining under the light microscope to observe the pathological changes.The pathological changes and expression of TGF-β1,a-SMA and Col-IV in renal interstitium were observed.Western blot analysis the protein expression of NF-κ B and p38MAPK in renal tissue.
Results:
(1) From the appearance point of view, treatment group of the earthworm in the corresponding time points of the obstructed kidney enlargement and stagnant water level were lighter and more red color than the UUO group.
(2) Rats in each group at different time points24hours urinary protein excretion was no significant difference (p>0.05)
(3)Scr and BUN levels of Earthworm groups were lower than UUO group at the2,4weeks after surgery (p<0.05. p<0.01).The same time.Scr and BUN level of Earthworm of low-dose group were lower than Earthworm high-dose group.
(4) Immunohistochemical results showed:the expressions of TGF-β1,a-SMA and Col-Ⅳ in renal tissue of UUO group and Earthworm groups increased gradually, with the extension of the time of obstruction. In the corresponding point in time,Earthworm of high-dose group and low-dose group compared with UUO group, TGF-beta1,a-SMA and Col-Ⅳ protein expression were significantly lower(p<0.05, p<0.01).
(5) Western blot showed:the expressions of NF-κB and p38MAPK gradually increased with the extension of the time of obstruction in UUO group and earthworm groups. The expressions of NF-κB and p38MAPK were significantly lower than that of UUO group at the corresponding time point in earthworm groups(p<0.05).
(6) Earthworm low-dose group was better than the high dose group to slow down the development of renal interstitial fibrosis.
Conclusion:
(1) The earthworm component could improve renal function of UUO rats through reducing serum creatinine,blood urea nitrogen level.
(2) The earthworm component could reduce renal fibrosis degree
(3) The earthworm component could delay the Progression of renal interstitial fibrosis,through decreasing the expressions of TGF-βl,a-SMA,Col-IV in UUO kidney tissue.
(4) The earthworm component may be slow down the development of renal interstitial fibrosis, through the many targets blocking TGF-β1→p38MAPK→NF-κ B signaling pathways.
方法：采用大鼠单侧输尿管梗阻法复制肾间质纤维化模型。将健康雄性Wistar大鼠60只,随机分组：假手术组12只,模型组16只,地龙低剂量组16只,地龙高剂量组16只。地龙低剂量组给-予地龙组分丝氨酸蛋白水解酶胶囊0.24g·kg1-·d-1灌胃；地龙高剂量组给予地龙组分丝氨酸蛋白水解酶胶囊0.48g·kg-1·d-1灌胃；假手术组和模型组给等量蒸馏水灌胃。分别于术后第2W、4W处死各组的6只大鼠,处死前一天收集24h尿量检测24h尿蛋白定量,处死当天收集静脉血用于血清肌酐(Scr)、尿素氮(BUN)指标的检测。取梗阻侧肾组织标本,HE染色后光镜下观察肾脏病理改变；免疫组织化学方法检测肾组织中TGF-β1、a-SMA、Col-Ⅳ的表达；Western blot检测肾组织中NF-κB、p38MAPK的蛋白表达
结果：
(1)从外观上看,与模型组相比,地龙治疗组在对应时间点上梗阻侧肾脏的肿大及积水程度较轻,色泽较红润。
(2)在不同的时间点各组大鼠24h尿蛋白定量无统计学差异(P>0.05)。
(3)地龙治疗组大鼠的Scr、BUN水平在第2、4W时均低于模型组(p<0.05或p<0.01)；相同时间点,地龙低剂量组大鼠血清Scr、 BUN水平低于地龙高剂量组。
(4)免疫组化结果显示：模型组及地龙治疗组大鼠肾组织中TGF-β1、a-SMA、Col-Ⅳ的表达随梗阻时间的延长,逐渐增多；在对应的时间点,地龙高、低剂量组与模型组大鼠相比,TGF-β1、 a-SMA、Col-Ⅳ的蛋白表达显著降低(p<0.05或p<0.01)。
(5)Western blot结果显示：随着梗阻时间的延长,模型组及地龙治疗组NF-κB、p38MAPK的表达逐渐增多,地龙治疗组NF-κB、p38MAPK的表达明显低于对应时间点模型组(p<0.05)。
(6)实验观察到地龙低剂量组疗效优于高剂量组
结论：
(1)地龙组分能够降低UUO模型大鼠的血清Scr、BUN水平具有保护肾功能作用。
(2)地龙组分能够改变肾脏组织形态、减轻肾间质纤维化程度,具有减轻UUO大鼠肾组织损伤作用
(3)地龙组分可能是通过下调α-SMA和Col-Ⅳ的表达来抑制成纤维细胞过度活化,减少ECM的过度积聚,来延缓肾间质纤维化的进展
(4)地龙组分可能是通过多靶点阻断TGF-β1→p3MAPK→NF-κB信号传导通路,来实现其延缓肾间质纤维化进程的作用
Objective:
To investigate the effect of earthworm component serine hydrolase on p38mitogen-actived protein kinase signaling pathway and nuelear factork kappa B of unilateral ureteralobstruction rats.and to illustrate the mechanism of the components of earthworm serine hydrolase on delaying renal interstitial fibrosis.
Method:
Copy the model of renal interstitial fibrosis in rats with unilateral ureteral obstructi on.The60male wistar rats were randomly divided into four groups:sham-operation group(12),UUO group (16), earthworm of low-dose group (16),earth worm of high-dose group (16). Earthworm of low-dose group was given the earthworm component of serine proteolytic enzymes capsules0.24g·kg-1·d-1to gavage.Earthworm of high-dose group was given the earthworm component of serine proteolytic enzymes capsules0.48g·kg-1·d-1to gavage.Sham operation group and UUO group were given the same dose of distilled water.6rats of each group were killed respectively at the2,4weeks after surgery.Put to death the day after the collection of24h urine detection of24urinary protein excretion, executed the same day to collect blood for serum creatinine (Scr),blood urea nitrogen(BUN)index detection. Take the obstructed kidney tissue specimens.HE staining under the light microscope to observe the pathological changes.The pathological changes and expression of TGF-β1,a-SMA and Col-IV in renal interstitium were observed.Western blot analysis the protein expression of NF-κ B and p38MAPK in renal tissue.
Results:
(1) From the appearance point of view, treatment group of the earthworm in the corresponding time points of the obstructed kidney enlargement and stagnant water level were lighter and more red color than the UUO group.
(2) Rats in each group at different time points24hours urinary protein excretion was no significant difference (p>0.05)
(3)Scr and BUN levels of Earthworm groups were lower than UUO group at the2,4weeks after surgery (p<0.05. p<0.01).The same time.Scr and BUN level of Earthworm of low-dose group were lower than Earthworm high-dose group.
(4) Immunohistochemical results showed:the expressions of TGF-β1,a-SMA and Col-Ⅳ in renal tissue of UUO group and Earthworm groups increased gradually, with the extension of the time of obstruction. In the corresponding point in time,Earthworm of high-dose group and low-dose group compared with UUO group, TGF-beta1,a-SMA and Col-Ⅳ protein expression were significantly lower(p<0.05, p<0.01).
(5) Western blot showed:the expressions of NF-κB and p38MAPK gradually increased with the extension of the time of obstruction in UUO group and earthworm groups. The expressions of NF-κB and p38MAPK were significantly lower than that of UUO group at the corresponding time point in earthworm groups(p<0.05).
(6) Earthworm low-dose group was better than the high dose group to slow down the development of renal interstitial fibrosis.
Conclusion:
(1) The earthworm component could improve renal function of UUO rats through reducing serum creatinine,blood urea nitrogen level.
(2) The earthworm component could reduce renal fibrosis degree
(3) The earthworm component could delay the Progression of renal interstitial fibrosis,through decreasing the expressions of TGF-βl,a-SMA,Col-IV in UUO kidney tissue.
(4) The earthworm component may be slow down the development of renal interstitial fibrosis, through the many targets blocking TGF-β1→p38MAPK→NF-κ B signaling pathways.
引文
[1]Eddy A A.Molecular basis of renal fibrosis.Pediatr Nephrol,2000,15(3-4): 290-301
[2]KlahrS, Morrissey JJ. Obstructive nephropathy and re-nal fibrosis [J].Am J PhysiolRenalPhysio, 2002,283:F861.
[3]宋跃飞,高峰,韩履祺,等.中医药治疗肾间质纤维化的研究进展.山西中医,2010,(12)：49-51
[4]徐云生.任继学教授治疗慢性肾功能衰竭的用药经验.吉林中医药.2000.1
[5]胡艳丽,等.李俊卿治疗慢性肾衰竭经验.天津中医.2001,18(6)：38
[6]聂莉芳.慢性肾衰竭的分期辨治经验与体会.中国中西药结合肾病杂志.2009,10(11)：941-942
[7]郑平东.性肾衰竭病因病机与临证辨治.上海中医药大学学报.2008,22(2)：1-3
[8]孙世竹,孙伟.抗肾纤维化中药复方配伍规律探讨.中国中西医结合肾病杂志.2005,6(12)：734-736
[9]林海英,等.益气活血降浊中药对单侧输尿管结扎大鼠肾脏结缔组织生长因子mRNA表达的影响.中国中西医结合肾病杂志,2004,5(11)：631-633
[10]王钊林,马华.中药芪红合剂对肾间质纤维化模型大鼠肾皮质中bcl-2表达的影响.山西中医学院学报,2006,7(4)：15-17
[11]曹微,师晶丽,李均.温阳活血方对大鼠肾间质TMP-1、MMP-3、FN的影响.世界中医药,2007,2(5)：306-308
[12]顾向晨,等.慢性肾衰竭现代文献中药复发用药规律初探.中国中西医结合肾病杂志,2008,9(7)：612-615
[13]丁俊生,刘丙欣.和络泄浊方对肾间质纤维化大鼠转化生长因子β1表达的影响.中医药学刊,2006,24(7)：1220-1221
[14]陶兴,等.浊毒理论在慢性肾衰竭中的应用及治疗策略.辽宁中医杂志.2008,35(10)：1495-1496
[15]杜治锋,杜治宏.从毒论治肾间质纤维化.陕西中医学院学报,2007,30(3)：3-4
[16]肾脏病.第一版.人民卫生出版社,2002：326-327
[17]王延辉,冯松杰.慢性肾衰竭中医辨证分型的文献分析.北京中医药,2009,28(3)：329-330
[18]陈丽芬,阮诗玮.温阳法在慢性肾衰治疗中的应用及研究进展.环球中医药,2009,2(2)：151-154
[19]张杰.戴恩来教授运用温阳法治疗慢性肾衰竭经验仁.亚太传统医药,2008,4(3)：54-55
[20]张琳琪,刘红亮.慢性肾衰竭中医邪实证证候分布规律.河南中医学院学报,2009,1(24)：61-62
[21]冯桂梅等.活血化瘀法治疗慢性肾衰竭的临床观察.中国中西医结合肾病杂志,2002,3(8)：479-480
[22]张艳枫.桃核承气汤合生姜泻心汤治疗慢性肾衰竭100例.河北中医,2009,21(7)：1020.
[23]栾洪文,王天祥,马彩霞.中医治疗慢性肾功能衰竭的几种方法.中国临床医药研究杂志,2003,(92)：9140.
[24]艾长生.益肾健脾活血泄浊方治疗慢性肾衰45例.世界中医药,2007,2(4)：226-277.
[25]张小鹿,陶明龙,黄芳.益肾泄浊化瘀汤治疗慢性肾衰竭临床观察.上海中医药杂志,2009,43(8)：37-38
[26]余国华,胡林豪,邹丽云,白发臣.自拟大黄降脂方延缓慢性肾衰竭临床观察.中国中西医结合肾病杂志,2008,9(11)：987-988
[27]许庆友,潘莉,王月华,王香婷,王筝,谷艳丽,张磊磊,丁英均,赵京山,杜明华.红花对肾间质纤维化实验大鼠肾小管上皮细胞表型转化的抑制作用.中国老年学杂志,2009.29(11)：1344-1346
[28]高燕,陈航,贾海红,袁爱军,袁鲁亮,王茹欣.红花黄色素对实验性肾间质纤维化大鼠TGF-β及Ⅰ型胶原表达的影响.医学研究与教育,2009,6(3)：11-13
[29]刘迟,郭刚,胡仲仪.莪术对单侧输尿管梗阻大鼠肾间质纤维化的影响.上海中医药杂志,2006,40(12)：71-73
[30]陆敏,周娟,王飞,刘煜敏,孙悦.川芎嗪对肾间质纤维化模型大鼠Smad7 和SnoN蛋白表达的影响.中国中药杂志,2009,34(1)：84-87
[31]丁庆余,宋恩峰,贾汝汉.杜仲对单侧输尿管梗阻大鼠肾间质纤维化的影响.中国中西医结合肾病杂志,2010,11(2)：109-111
[32]韦颖,樊均明,潘丽萍.三七总甙对大肾成纤维细胞的影响.中国中两医结合杂志,2002,22(1)：47-49
[33]谢红东,杨珂,穆焕德,魏世道,张永煜、刘成海.黄芩提取物对大鼠肾间质纤维化的作用及其抗氧化机制.中国中西医结合肾病杂志,2009,10(3)：240-242
[34]冯媛,刘敏,张苗,何劲松.黄蜀葵花总黄酮对单侧输尿管梗阻大鼠肾间质纤维化的影响.中国中西医结合肾病杂志,2010,11(11)：1006-1008
[35]闵亚丽,于黔,肖俊.冬虫夏草在肾间质纤维化大鼠模型中的作用及其对TGF-β1、α -SMA的影响.中国中西医结合肾病杂志,2007,8(2)：92-93
[36]王亚平,李伯祥,于海泉,等.红景天改善实验性大鼠肾间质纤维化的研究中国中医药信息杂志,1998,5(11)：21-22
[37]孙万森.绞股监总皂苷抗大鼠肾纤维化的实验研究.中国中医药科技,1998,5(1)：21-22
[38]付平,冯梅,张翥,等.苦参碱对单侧输尿管梗阻模型大鼠肾小管间质纤维化的影响.中国中两医结合杂志,2006,26(2)：140-143
[39]周萍.丹参红景天合剂对大鼠肾间质纤维化CTGF表达的影响.中国医药导报,2008,5(4)：27-28
[40]孟立强,屈磊,李晓玫.黄芪当归合剂对肾间质纤维化的多靶点抑制作用中国药理学通报,2006,22(3)：296-302
[41]马晓鹏,宋立群,于思明,马艳春.虫草肾茶颗粒对单侧输尿管结扎致肾间质纤维化大鼠肾脏影响的研究.中国临床保健杂志,2010,13(4)：385-388
[42]乔颖进,谌贻璞,芮宏亮,董鸿瑞,刘章锁.肾康注射液对慢性马兜铃酸肾病模型大鼠肾间质纤维化的拮抗作用.中草药Chinese Traditional and Herbal Drugs,2009.40(4):587-592
[43]叶婷婷,沈建明,邓妍妍,王黎萍,田林,田少江,李骏峰,刁路明.肾炎康复片对大鼠肾间质纤维化的保护作用.勋阳医院学报(J Ynk),2008,27(5)：401-404
[44]阮君山,等.解毒复肾逐瘀方对肾纤维化大鼠CTGF及TGF-β1表达的影响.中国临床研究,2011.3(17)：9-11
[45]何立群,王怡,高建东.抗纤灵冲剂对慢性肾衰纤维化及其影响因素的研究[J].科研成果,2003,32(7)：20-22
[46]晏子友,皮持衡,高书亮,等.化瘀解毒汤抗肾间质纤维化的实验研究.中国中医基础医学杂志,2001,7(9)：35-38.
[47]晏子友,郭有能,高书亮,等.化瘀解毒汤对TGF-β1及MMPlmRNA基因表达作用的探讨.中国中西医结合肾病杂志,2001,2(9)：515-517.
[48]魏连波,马志刚,吕瑞和,等.大黄蟅虫丸对大鼠肾间质纤维化及TGF-β1表达的影响[J].中国中西医结合杂志,2003,23(基础理论研究特集)：115-117.
[49]马志刚,魏连波,吕瑞和.等.大黄蟅虫丸对肾间质纤维化影响的实验研究[J].中国中西医结合肾病杂志,2001,2(12)：689-691.
[50]孙伟,陈继红,高坤,等.大黄蟅虫丸对阿霉素肾硬化大鼠系膜基质增生抑制作用的实验研究[J].江苏中医药,2008,40(1)：77-79.
[51]孙伟,朱萱萱,曾安平,等.大黄蟅虫丸对改良阿霉素肾病肾硬化大鼠模型作用的实验研究[J].中成药,2006,28(1)：81-85.
[52]中国肾脏病学.第一版.人民军医出版社,2008：1077
[53]Nath KA.Kideny Int,1998,53:992-994
[54]Fine LG, Orphanides C, Norman JT. Progressive renal disease:The chronic hypoxia hy pothesi s [J]. Kidney Int,1998,53 (supp 165):S74-S78.
[55]Norman JT, Clark IM, Garcia PL. Hypoxia promotes fibrogen-es i s in human renal fi brobl asts[J]. Kidney Int,2000.58(6):2351-2366.
[56]Eisberg M,Kal luri R.The role of epithelial-to-mesenchymal transition in renal fibrosis.J Mol Med,2004,82:175-181.
[57]Wano M.Evidence that fibroblasts derive from pithelium during tissue fibrosis. J Clinlnvest,2002,110:341-350.
[58]Kalluri R.Neilson EG.Epithelial-mesenchymal transition and its implications for fibrosis.J Clin I nves t,2003,112:1776-1784.
[59]ZeisbergM.Bone morphogenic protein-7 inhibits progression of chronic renal fib'rosis associatedwith two genetic mouse models.Am J Physiol Renal Physiol.2003,285:F1060-F1067.
[60]Zeisberg M.BMP-7 counteracts TGF-β1 induced epithelial-to-mesen chymal transition and reverses chronic renal injury.NatMed.2003.9:964-968.
[61]Yang J,Liu YL. Dissection of key events in tubular epithelical to myfi broblast transition and its implication in renal interstitial fibrosis.Am J Pa thol,2001,159(4):1465-1475
[62]Gavrilova SI,Kolykhalov Ⅳ,Korovaitseva GI,et al.ApoE geno-type and efficacy of neurotrophic and cholinergic therapy in Alzheimets disease [J].Zh Nevrol Psikhiatr Im S S Korsakova,2005,105 (4):27-34
[63]Zeisberg M,Hanai J,Sugimoto H,et al.BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.Nat Med,2003,9(7):964-968.
[64]Zeisberg M,Bottiglioc, Kumar N,et al.Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models.Am J Physiol Renal Physiol,2003,285 (6):F1060-F1067.
[65]JeremiahMorrissey, KeithH ruska, GuangjieGuo, et al. BMP-7improve renal fibrosis and accelerates the return of renal function [J].JAm SocNephro,l 2002,13:14
[66]Yang J,Liu Y. Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol,2003,284(2):F349-F357.
[67]黄云剑,梁德平,赵景宏,等.肝细胞生长因子缓解梗阻性肾病肾小管间质纤维化[J].重庆医学,2003,32(6)：650
[68]Pirk E,Heldin CH,Ten-Dijke P·Specificity,diversity,and regulation in TGF-β supefamily signaling[J].FA SED Journal,1999,13(15):2105-2124
[69]Schiffer M,Von Gersdorff G,Bitzer M,et al.Smad proteins and trans-forming growth factor-beta signaling[J].Kidney Int Suppl,2000,(77):45-5
[70]Isono M, Chen S,Hong SW.et al.Smad pathway is activated in the diabetic mouse kidney and Smad3 mediatesTGF-beta-induced fibronectin in mesangial cells[J].Biochem Biophys Res Com mun,2002,296(5):1356-1365
[71]Rerolle JP, HertigA. Nguyen G, et al. Plasm inogen activator inhibitor-type 1 is a potential target in renal fi brogenesis[J].Kidney Int,2000,58(5): 1841-1850.
[72]SibalicV, Sun L, SibalicA, et al. Characteristic matrix and tubular basement membrane abnormalities in the CBA/Ca-kdkd mouse model of hereditary tubul ointerstitial disease[J]. Neph-ron,1998,80(3):305-313.
[73]刘会卿,等.伊贝沙坦抑制大鼠单侧输尿管梗阻模型肾间质纤维化.河北医药,2008,30(12)：1860-1861
[74]王琳娜,陶立坚,宁旺斌.依那普利对单侧输尿管梗阻大鼠肾间质纤维化的防治作用.中南大学学报(医学版),2008,33(9)：841-847
[75]张超,等.普伐他丁对UUO大鼠肾间质P38MAPK活性影响的研究.中国中西医结合肾病杂志,2008,9(2)：158-160
[76]张国欣,等.阿托伐他汀对单侧输尿管梗阻大鼠肾小管间质纤维化的保护作用.河北医药,2010,32(16)：2165-2167
[77]Zhou A,Ueno H,Shimomura M,et al.Blockade of TGF-beta actioname liorates renal dysfunction and histologic progression in anti-GBM neph ritis.Kidney Int,2003,64(1):92-101
[78]Yokoi H,Mukoyama M,Nagae T,et al.Reduction in connective tissue growth factor by an ti sense treatment amelioratesrenal tubulointerstitial fibrosis.J Am Soc Nephrol,2004,15 (6):1430-1440.
[79]Yang J,Dai C,Liu Y.Hepatocyte growth factor gene therapy and angiotensin Ⅱ blockade synergistically attenuate renal interstitial fibrosis inmice. J Am Soc Nephrol,2002,13 (10):2464-2477.
[80]Border WA,Okuda S,Languino LR,et al.Suppressio n of experimental glomerulonephritis by antiserum against transforming growth factor betal[J]Nature,1990,346:371-374
[81]Meldrum KK, Meldrum DR,Hile KL,et al. p38MAPK mediates renal tubular cell TNF-alpha production and TNF-alpha-dependent apoptosis during simulated ischemia.Am J Physiol Cell Physiol,2001,281:C563-C570
[82]Zhang M,Tang JW,Li XM, et al. In terleukin-1 bera-induced trans-diff erentiation of renal proximal tubular cells is mediated by p38 mitogen-activated protein kinase phosphorylation.Zhonghua Yi Xue Za Z h i,2003, 83:1161-1165
[83]Brewster JL,De Val oirT,D wy er N.et al.An osmosensing signal trans-duction pathway in yeast[J]. Science,1993,259(5099):1760-1763.
[84]Berra E, Diaz-MecoMT, Moscat J. The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phophoinositide 3-kinase/Akt pathway [J]. J BoilChem,1998,273 (17):10792-10797.
[85]Xia Z, DickensM, Raingeaud J,et al. Opposing effects of ERK and JNK-p38MAP kinases on apoptos is[J]. Science,1995,270 (5240):1326-133 1.
[86]StoneleyM,ChappeIlSA, JoplingCL. c-Myc protein synthesis is initiated from the internal ribosome entry segment during apoptosis[J]. MolCellBio,I 2000,20(4):1162-1169.
[87]Bulavin DV, Saito S,Hollander MC. Phosphory lation ofhuman p53 by p38 kinase coord inatesN-term in al phosphory lat ion and apoptosis in response to UV radiation[J].EMBO J,1999,18(23):6845-6854.
[88]Kornmann M, Ishiwata T, Kleeff J. Fas and Fas-ligand expression in human pancreatic cancer[J]. Ann Surg,2000,231(3):368-379.
[89]Ghatan S,Laner S,Kinoshita Y.p38MAPK kinase mediates bax transl-ocation in nitric oxide-induced apoptosis inncurons[J]. J CellBio,1200 0,150(2):335-347.
[90]阮颖新,刘素雁,李春媚,等.单侧输尿管梗阻大鼠模型中p38MAPK表达与细胞凋亡.中国病理生理杂志,2008,24(4)：749-754.
[91]水华,丁国华.p38信号通路对单侧输尿管结扎大鼠RANTES的影响.中华急诊医学杂志,2006,15(8)：706-709
[92]张梅,唐嘉薇,李晓玫.1L-1β通过p38MAPK信号途径诱导肾小管细胞转 分化并影响其移行功能[J].中华医学杂志,2003.83(13)：1161-1165.
[93]Balwin A S.The NF-κB and IκB Proteins:new Discoveries and Insigh ts[J].Annu Rev I mmunol,1996,14:649-683.
[94]Auwardt R,Mudge SJ,Chen C,etal.Regulation of nuclear factor B by corticosteroidsinrat mesangial cells [J]. J Am Soc Nephrol,1998.9:1620-1628.
[95]张爱华,陈荣华,黄松明,等.阿霉素肾病大鼠肾组织中核因子-κB活化与肾小管间质损害的关系[J].南京医科大学学报,2001,21(1)：6-9.
[96]Whiteside ST Israel A.IB Proteins:structure, function and regulation [J].Semin Cancer B iol,1997,8:75-82.
[97]Bonizzi G,KarinM.The two NF-kappaB activation pathways and their role in innate and adaptive immunity Trends Immunol 2004;25:280-288
[98]Luo JL,Kamata H,Karin M. IK K/N F-kappaB signaling:balancing life and death-a new approach to cancer therapy,J Clin Invest 2005; 115:2625-2632
[99]LiZ W,Chu W,Hu Y,Delhase M,Deerinek T, Ellisman M,Johnson R,K arin M.The IKBeta subunit of IkappaB kinase(lKK)is essential for ucle ar factor kaPPaB activation and Prevention of apoptosis.J Exp Med 19 99; 189:1839-1845
[100]Seftleben U,Cao Y,Xiao G,Greten FR,Krahn G,Bonizzi G,Chen Y,Hu Y,Fong A,Sun SC,Karin M. Activation by IKKalPha of a second, evolutionary eonserved, NF-kaPPaB signaling pathway.Scienee 2001;293:1495-1499
[101]Xavicr RJ.et al.2000,Science,289:1483-1484.
[102]Karin M et al.2000,Semin 1mmunol,12:85-98.
[103]HinzM,Krappmann D,Eichten A, et al.NF-kappa B Function in Gro-wth C ontrol:Regul ati on of CyclinDl Expression and G0/G1-to-S-ph ase transition[J].Mol Cell Biol,1999,19(4):2690-2698.
[104]Gui jarroC. Central Role of the Transcription Factor Nuclear Factor Kappa-B in Mesangial Cell Production of Chemokines[J].Contrib Nephro-1,1997,120:210-218.
[105]Tergaonk ar V,Pando M,Vafa O.et al.p53 stabilization is decreased upon NF kappaB activation:a role for NfkappaB in acquisition of resistance to chemotherapy.Cancer Cell,2002,1(5):493-503.
[106]裘奇,刘志红.核因子-κB的分子生物学特性及其在细胞凋亡中的作用.肾脏病与透析肾移植杂志,1997,6(3)：246-248.
[107]FukudaK,Yoshitomi K,Yanagida T,etal.Quantification of TGF-β1mRNA along rat nephron in obstructive nephropathy.Am J Physiol Renal Physiol,2001,281(3):F513-F521.
[108]WangY, Rangan GK, et al. Induction of monocyte chemoattractan t protein-1 by albumin ismediated by nuclear factor kappaB in proximal tubule cells. J Am Soc Nephrol 1999,10(6):1204-13.
[109]Han H J,Oh Y J,Lee Y J.Effect of Albumin on 14C-al pha-Methy 1-D-G lu copyranoside Uptake in Primary Cultured Renal Proximal Tubule Cells:lnvolvement of PLC,M A PK,an d NF-κB [J].Cell Phy siol.2005,202(1): 246-254.
[110]Komiya T,Miura K.Tsulamoto J,et al.Possible Involvement of Nuclear Factor-kappa B Inhibition in the Renal Protective Efect of Oral Adsorbent AST-120 in a Rat Model of Chronic Renal Failure[J].Int J Mol Med,2004,13(1):133-138.
[111]Barnes P J, Karin M. Nuclear Factor-kappa B:a Pivotal Tran scrip-tion Factor in Chronic Inflammatory Diseases[J].N Engl J Med,1997,3 36(15):1066-1071
[112]GrossML, HankeW, KochA, et al. I ntraperi tonealp rotein injection in the axolot:the amphibian kidney as a novel model to study tubu-lointerstitial activation[J].Kidney Int,2002,62:51.
[113]KANETO H,MORRISSEY J.KLAHR S.Increased expression of TGF-β1 Mrna in the obstructed kidney of rats with unilateral ureteral ligati on[J].Kidney Int,1993,44(6):313-321.
[114]Klahr S, Morrissey J. Obstructive nephropathy and renal fibrosis [J] Am J Physiol Renal Physiol,2002,283(5):861-875
[115]Yang, Jun Wei, Liu You Hua-Blockage of tubular epithelial to my-ofibroblast transition by hepatocyte growth factorprevents renal intersti tial fibrosis [J] J Am Soc N ephrol.2002,13 (1):96-107.
[116]Qi W, Chen X, Poronnik P, et al. The renal cortical fibroblast inrenal tubulointerstitial fibrosis [J]. Int J Biochem Cell Biol.2006,38(I):I-5.
[117]Picard N, BaumO, Vogetseder A, et al. Origin of renal myofibro-blasts in the model of unilateral ureter obstruction in the rat [J]. His-tochem Cell Biol,2008,130(1):141-155.
[118]PakkanenO, HamalainenE, KivirikkoK, et, al.Aessmblyof Stable Human TyPe and IllCollagen Moleeules From Hydroxylatedre combinant Chains In the Yeast Piehia Pastoris[J].The Journal of Biological Chemistry,2003, 278(34):32478-32482.
[119]康丽华.胶原蛋白与肝纤维化[J].中国疗养医学.2006,15(6)：417-419
[120]孙柱,徐曼,邹万忠.肾小管间质纤维化中转化生长因子的表达特征.中华肾脏病杂志,2000,16：291
[121]Kaneto H,Ohtani H,Fukuzaki A,et al.Increased expression of TGF-β1 but not of its receptors contributes to human obstructive nephropat-hy. Kidney Int,1999,56(6):2137-46.
[122]Stambe C, Atkins R C,Tesch G H, et al.The Role of p38alpha Mitogen2 Activated Protein Kinase activa2tion in renal fibrosis[J]. J Am Soc Nephrol,2004,15 (2):370-379.
[123]Zhang Z,Cohen DM,et,al. NaCl but not urea activates p38 and JU N kinase in Mimed3 murine inner medullary cells.J Biochem,1996,271(6 Pt2):F 1234-F1238.
[124]Ge lei leteTJ,Mel oGC.GostaRS,etal.Rol eof yofibro blasts, mac rophages, transforming growth factor-beta endothelin, angiotensinll,an d fibronectin the progression of tubuloin-terstitial nephritis induced by gentamicin.J Nephrol,2002,15(6):633-642
[125]祝胜郎,余学清,娄宁,等P38MAPK在火鼠梗阻性肾病肾组织中的表达及可能作用[J].中国病理生理杂志,2004,20(4)：545-549.
[126]杨继红,郑法雷,吴华,等.他克莫司对转化生长因子-β诱导的肾小管上 皮细胞转分化的抑制作用及对核因子-活性的影响.肾脏病与透析肾移植杂志,2004,13(2)：124-128.
[127]干永钧,张敏鸥.痰瘀互结与肾内微型癥积[J].中国中两医结合肾病杂志,2003,4(1)：1
[128]Magnatri P Fishers J,Globus R K.Extrace llularmatrix remodeling by metallo proteinases and plasminogen activator.Kidney Int,1995,47(Suppl): 12.14
[129]盛丽,等.水蛭、地龙抗实验性小鼠肺纤维化作用的研究.中医研究,2006,19(2)：15-17
[130]陈洪,陆亚琴,刘顺英,等.地龙2号对大鼠肝纤维化TGF-β1.MMP-13及TIMP-1mRN A和白表达的影响[J]世界华大消化杂志,2004,12(10)：354-356.
[131]陈洪,陆亚琴,刘顺英,等.地龙2号对大鼠肝纤维化α-SMA、TGF-β1.MMP-13及TIMP-1蛋白表达的影响[J]胃肠病学和肝病学杂志,2005,14(2)：443-446
[132]陈洪,陆亚琴,刘顺英,等.地龙2号对肝纤维化模型大鼠肝星状细胞活化及TG-β1蛋白表达的影响[J].江苏中医药,2005,26(1)：50-52
[133]陆亚琴,等.地龙2号抑制大鼠肝纤维化的研究.胃肠病学和肝病学杂志,2004,13(3)：225-227
[134]陈洪,等.蚯蚓提取物对肝纤维化大鼠α-SMA、TGF-β1、uPA及PA1-1蛋白表达的影响.江苏医药,2005,31(6)：443-445
[135]马艳春,周波,孙许涛,等.MTT法检测地龙有效成分对肾小球系膜细胞增殖的影响.中医药信息,2010,27(1)：34-36
[136]薛痕,樊均明,陈亮,等.大鼠肾间质纤维化动物模型的实验研究.四川动物,2004,23(1)：16-20
[137]Strutz F.Transdifferentiation:a new concept in renal fibrogenesis. J Am Soc Nephrol,1994,5:819-822.
[138]张志新,黄迪,吴锋,等TGF-β1/p38MAPK通路对肾间质纤维化影响及抗纤灵冲剂干预机制的实验研究.中华中医药杂志,2011,2(2)：245-248
[139]O'Donnell MP.Renal tubulointerstitial fibrosis:new thoughs on its development and progression.Postgrad Med.2000,108:159-172.
[140]余学清,祝胜郎.娄宁,等.依那普利对梗阻性肾病大鼠肾组织p38MAPK丝裂素激活蛋白激酶活性的影响.中华肾脏病杂志,2004,20(3)：181-185
[141]Morrissey J, Klahr S. Transcription factor NF-kappaB regulation of renal fibrosis during ureteral obstruction. Semin Nephrol 1998,18(6): 603-11
[2]KlahrS, Morrissey JJ. Obstructive nephropathy and re-nal fibrosis [J].Am J PhysiolRenalPhysio, 2002,283:F861.
[3]宋跃飞,高峰,韩履祺,等.中医药治疗肾间质纤维化的研究进展.山西中医,2010,(12)：49-51
[4]徐云生.任继学教授治疗慢性肾功能衰竭的用药经验.吉林中医药.2000.1
[5]胡艳丽,等.李俊卿治疗慢性肾衰竭经验.天津中医.2001,18(6)：38
[6]聂莉芳.慢性肾衰竭的分期辨治经验与体会.中国中西药结合肾病杂志.2009,10(11)：941-942
[7]郑平东.性肾衰竭病因病机与临证辨治.上海中医药大学学报.2008,22(2)：1-3
[8]孙世竹,孙伟.抗肾纤维化中药复方配伍规律探讨.中国中西医结合肾病杂志.2005,6(12)：734-736
[9]林海英,等.益气活血降浊中药对单侧输尿管结扎大鼠肾脏结缔组织生长因子mRNA表达的影响.中国中西医结合肾病杂志,2004,5(11)：631-633
[10]王钊林,马华.中药芪红合剂对肾间质纤维化模型大鼠肾皮质中bcl-2表达的影响.山西中医学院学报,2006,7(4)：15-17
[11]曹微,师晶丽,李均.温阳活血方对大鼠肾间质TMP-1、MMP-3、FN的影响.世界中医药,2007,2(5)：306-308
[12]顾向晨,等.慢性肾衰竭现代文献中药复发用药规律初探.中国中西医结合肾病杂志,2008,9(7)：612-615
[13]丁俊生,刘丙欣.和络泄浊方对肾间质纤维化大鼠转化生长因子β1表达的影响.中医药学刊,2006,24(7)：1220-1221
[14]陶兴,等.浊毒理论在慢性肾衰竭中的应用及治疗策略.辽宁中医杂志.2008,35(10)：1495-1496
[15]杜治锋,杜治宏.从毒论治肾间质纤维化.陕西中医学院学报,2007,30(3)：3-4
[16]肾脏病.第一版.人民卫生出版社,2002：326-327
[17]王延辉,冯松杰.慢性肾衰竭中医辨证分型的文献分析.北京中医药,2009,28(3)：329-330
[18]陈丽芬,阮诗玮.温阳法在慢性肾衰治疗中的应用及研究进展.环球中医药,2009,2(2)：151-154
[19]张杰.戴恩来教授运用温阳法治疗慢性肾衰竭经验仁.亚太传统医药,2008,4(3)：54-55
[20]张琳琪,刘红亮.慢性肾衰竭中医邪实证证候分布规律.河南中医学院学报,2009,1(24)：61-62
[21]冯桂梅等.活血化瘀法治疗慢性肾衰竭的临床观察.中国中西医结合肾病杂志,2002,3(8)：479-480
[22]张艳枫.桃核承气汤合生姜泻心汤治疗慢性肾衰竭100例.河北中医,2009,21(7)：1020.
[23]栾洪文,王天祥,马彩霞.中医治疗慢性肾功能衰竭的几种方法.中国临床医药研究杂志,2003,(92)：9140.
[24]艾长生.益肾健脾活血泄浊方治疗慢性肾衰45例.世界中医药,2007,2(4)：226-277.
[25]张小鹿,陶明龙,黄芳.益肾泄浊化瘀汤治疗慢性肾衰竭临床观察.上海中医药杂志,2009,43(8)：37-38
[26]余国华,胡林豪,邹丽云,白发臣.自拟大黄降脂方延缓慢性肾衰竭临床观察.中国中西医结合肾病杂志,2008,9(11)：987-988
[27]许庆友,潘莉,王月华,王香婷,王筝,谷艳丽,张磊磊,丁英均,赵京山,杜明华.红花对肾间质纤维化实验大鼠肾小管上皮细胞表型转化的抑制作用.中国老年学杂志,2009.29(11)：1344-1346
[28]高燕,陈航,贾海红,袁爱军,袁鲁亮,王茹欣.红花黄色素对实验性肾间质纤维化大鼠TGF-β及Ⅰ型胶原表达的影响.医学研究与教育,2009,6(3)：11-13
[29]刘迟,郭刚,胡仲仪.莪术对单侧输尿管梗阻大鼠肾间质纤维化的影响.上海中医药杂志,2006,40(12)：71-73
[30]陆敏,周娟,王飞,刘煜敏,孙悦.川芎嗪对肾间质纤维化模型大鼠Smad7 和SnoN蛋白表达的影响.中国中药杂志,2009,34(1)：84-87
[31]丁庆余,宋恩峰,贾汝汉.杜仲对单侧输尿管梗阻大鼠肾间质纤维化的影响.中国中西医结合肾病杂志,2010,11(2)：109-111
[32]韦颖,樊均明,潘丽萍.三七总甙对大肾成纤维细胞的影响.中国中两医结合杂志,2002,22(1)：47-49
[33]谢红东,杨珂,穆焕德,魏世道,张永煜、刘成海.黄芩提取物对大鼠肾间质纤维化的作用及其抗氧化机制.中国中西医结合肾病杂志,2009,10(3)：240-242
[34]冯媛,刘敏,张苗,何劲松.黄蜀葵花总黄酮对单侧输尿管梗阻大鼠肾间质纤维化的影响.中国中西医结合肾病杂志,2010,11(11)：1006-1008
[35]闵亚丽,于黔,肖俊.冬虫夏草在肾间质纤维化大鼠模型中的作用及其对TGF-β1、α -SMA的影响.中国中西医结合肾病杂志,2007,8(2)：92-93
[36]王亚平,李伯祥,于海泉,等.红景天改善实验性大鼠肾间质纤维化的研究中国中医药信息杂志,1998,5(11)：21-22
[37]孙万森.绞股监总皂苷抗大鼠肾纤维化的实验研究.中国中医药科技,1998,5(1)：21-22
[38]付平,冯梅,张翥,等.苦参碱对单侧输尿管梗阻模型大鼠肾小管间质纤维化的影响.中国中两医结合杂志,2006,26(2)：140-143
[39]周萍.丹参红景天合剂对大鼠肾间质纤维化CTGF表达的影响.中国医药导报,2008,5(4)：27-28
[40]孟立强,屈磊,李晓玫.黄芪当归合剂对肾间质纤维化的多靶点抑制作用中国药理学通报,2006,22(3)：296-302
[41]马晓鹏,宋立群,于思明,马艳春.虫草肾茶颗粒对单侧输尿管结扎致肾间质纤维化大鼠肾脏影响的研究.中国临床保健杂志,2010,13(4)：385-388
[42]乔颖进,谌贻璞,芮宏亮,董鸿瑞,刘章锁.肾康注射液对慢性马兜铃酸肾病模型大鼠肾间质纤维化的拮抗作用.中草药Chinese Traditional and Herbal Drugs,2009.40(4):587-592
[43]叶婷婷,沈建明,邓妍妍,王黎萍,田林,田少江,李骏峰,刁路明.肾炎康复片对大鼠肾间质纤维化的保护作用.勋阳医院学报(J Ynk),2008,27(5)：401-404
[44]阮君山,等.解毒复肾逐瘀方对肾纤维化大鼠CTGF及TGF-β1表达的影响.中国临床研究,2011.3(17)：9-11
[45]何立群,王怡,高建东.抗纤灵冲剂对慢性肾衰纤维化及其影响因素的研究[J].科研成果,2003,32(7)：20-22
[46]晏子友,皮持衡,高书亮,等.化瘀解毒汤抗肾间质纤维化的实验研究.中国中医基础医学杂志,2001,7(9)：35-38.
[47]晏子友,郭有能,高书亮,等.化瘀解毒汤对TGF-β1及MMPlmRNA基因表达作用的探讨.中国中西医结合肾病杂志,2001,2(9)：515-517.
[48]魏连波,马志刚,吕瑞和,等.大黄蟅虫丸对大鼠肾间质纤维化及TGF-β1表达的影响[J].中国中西医结合杂志,2003,23(基础理论研究特集)：115-117.
[49]马志刚,魏连波,吕瑞和.等.大黄蟅虫丸对肾间质纤维化影响的实验研究[J].中国中西医结合肾病杂志,2001,2(12)：689-691.
[50]孙伟,陈继红,高坤,等.大黄蟅虫丸对阿霉素肾硬化大鼠系膜基质增生抑制作用的实验研究[J].江苏中医药,2008,40(1)：77-79.
[51]孙伟,朱萱萱,曾安平,等.大黄蟅虫丸对改良阿霉素肾病肾硬化大鼠模型作用的实验研究[J].中成药,2006,28(1)：81-85.
[52]中国肾脏病学.第一版.人民军医出版社,2008：1077
[53]Nath KA.Kideny Int,1998,53:992-994
[54]Fine LG, Orphanides C, Norman JT. Progressive renal disease:The chronic hypoxia hy pothesi s [J]. Kidney Int,1998,53 (supp 165):S74-S78.
[55]Norman JT, Clark IM, Garcia PL. Hypoxia promotes fibrogen-es i s in human renal fi brobl asts[J]. Kidney Int,2000.58(6):2351-2366.
[56]Eisberg M,Kal luri R.The role of epithelial-to-mesenchymal transition in renal fibrosis.J Mol Med,2004,82:175-181.
[57]Wano M.Evidence that fibroblasts derive from pithelium during tissue fibrosis. J Clinlnvest,2002,110:341-350.
[58]Kalluri R.Neilson EG.Epithelial-mesenchymal transition and its implications for fibrosis.J Clin I nves t,2003,112:1776-1784.
[59]ZeisbergM.Bone morphogenic protein-7 inhibits progression of chronic renal fib'rosis associatedwith two genetic mouse models.Am J Physiol Renal Physiol.2003,285:F1060-F1067.
[60]Zeisberg M.BMP-7 counteracts TGF-β1 induced epithelial-to-mesen chymal transition and reverses chronic renal injury.NatMed.2003.9:964-968.
[61]Yang J,Liu YL. Dissection of key events in tubular epithelical to myfi broblast transition and its implication in renal interstitial fibrosis.Am J Pa thol,2001,159(4):1465-1475
[62]Gavrilova SI,Kolykhalov Ⅳ,Korovaitseva GI,et al.ApoE geno-type and efficacy of neurotrophic and cholinergic therapy in Alzheimets disease [J].Zh Nevrol Psikhiatr Im S S Korsakova,2005,105 (4):27-34
[63]Zeisberg M,Hanai J,Sugimoto H,et al.BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.Nat Med,2003,9(7):964-968.
[64]Zeisberg M,Bottiglioc, Kumar N,et al.Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models.Am J Physiol Renal Physiol,2003,285 (6):F1060-F1067.
[65]JeremiahMorrissey, KeithH ruska, GuangjieGuo, et al. BMP-7improve renal fibrosis and accelerates the return of renal function [J].JAm SocNephro,l 2002,13:14
[66]Yang J,Liu Y. Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol,2003,284(2):F349-F357.
[67]黄云剑,梁德平,赵景宏,等.肝细胞生长因子缓解梗阻性肾病肾小管间质纤维化[J].重庆医学,2003,32(6)：650
[68]Pirk E,Heldin CH,Ten-Dijke P·Specificity,diversity,and regulation in TGF-β supefamily signaling[J].FA SED Journal,1999,13(15):2105-2124
[69]Schiffer M,Von Gersdorff G,Bitzer M,et al.Smad proteins and trans-forming growth factor-beta signaling[J].Kidney Int Suppl,2000,(77):45-5
[70]Isono M, Chen S,Hong SW.et al.Smad pathway is activated in the diabetic mouse kidney and Smad3 mediatesTGF-beta-induced fibronectin in mesangial cells[J].Biochem Biophys Res Com mun,2002,296(5):1356-1365
[71]Rerolle JP, HertigA. Nguyen G, et al. Plasm inogen activator inhibitor-type 1 is a potential target in renal fi brogenesis[J].Kidney Int,2000,58(5): 1841-1850.
[72]SibalicV, Sun L, SibalicA, et al. Characteristic matrix and tubular basement membrane abnormalities in the CBA/Ca-kdkd mouse model of hereditary tubul ointerstitial disease[J]. Neph-ron,1998,80(3):305-313.
[73]刘会卿,等.伊贝沙坦抑制大鼠单侧输尿管梗阻模型肾间质纤维化.河北医药,2008,30(12)：1860-1861
[74]王琳娜,陶立坚,宁旺斌.依那普利对单侧输尿管梗阻大鼠肾间质纤维化的防治作用.中南大学学报(医学版),2008,33(9)：841-847
[75]张超,等.普伐他丁对UUO大鼠肾间质P38MAPK活性影响的研究.中国中西医结合肾病杂志,2008,9(2)：158-160
[76]张国欣,等.阿托伐他汀对单侧输尿管梗阻大鼠肾小管间质纤维化的保护作用.河北医药,2010,32(16)：2165-2167
[77]Zhou A,Ueno H,Shimomura M,et al.Blockade of TGF-beta actioname liorates renal dysfunction and histologic progression in anti-GBM neph ritis.Kidney Int,2003,64(1):92-101
[78]Yokoi H,Mukoyama M,Nagae T,et al.Reduction in connective tissue growth factor by an ti sense treatment amelioratesrenal tubulointerstitial fibrosis.J Am Soc Nephrol,2004,15 (6):1430-1440.
[79]Yang J,Dai C,Liu Y.Hepatocyte growth factor gene therapy and angiotensin Ⅱ blockade synergistically attenuate renal interstitial fibrosis inmice. J Am Soc Nephrol,2002,13 (10):2464-2477.
[80]Border WA,Okuda S,Languino LR,et al.Suppressio n of experimental glomerulonephritis by antiserum against transforming growth factor betal[J]Nature,1990,346:371-374
[81]Meldrum KK, Meldrum DR,Hile KL,et al. p38MAPK mediates renal tubular cell TNF-alpha production and TNF-alpha-dependent apoptosis during simulated ischemia.Am J Physiol Cell Physiol,2001,281:C563-C570
[82]Zhang M,Tang JW,Li XM, et al. In terleukin-1 bera-induced trans-diff erentiation of renal proximal tubular cells is mediated by p38 mitogen-activated protein kinase phosphorylation.Zhonghua Yi Xue Za Z h i,2003, 83:1161-1165
[83]Brewster JL,De Val oirT,D wy er N.et al.An osmosensing signal trans-duction pathway in yeast[J]. Science,1993,259(5099):1760-1763.
[84]Berra E, Diaz-MecoMT, Moscat J. The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phophoinositide 3-kinase/Akt pathway [J]. J BoilChem,1998,273 (17):10792-10797.
[85]Xia Z, DickensM, Raingeaud J,et al. Opposing effects of ERK and JNK-p38MAP kinases on apoptos is[J]. Science,1995,270 (5240):1326-133 1.
[86]StoneleyM,ChappeIlSA, JoplingCL. c-Myc protein synthesis is initiated from the internal ribosome entry segment during apoptosis[J]. MolCellBio,I 2000,20(4):1162-1169.
[87]Bulavin DV, Saito S,Hollander MC. Phosphory lation ofhuman p53 by p38 kinase coord inatesN-term in al phosphory lat ion and apoptosis in response to UV radiation[J].EMBO J,1999,18(23):6845-6854.
[88]Kornmann M, Ishiwata T, Kleeff J. Fas and Fas-ligand expression in human pancreatic cancer[J]. Ann Surg,2000,231(3):368-379.
[89]Ghatan S,Laner S,Kinoshita Y.p38MAPK kinase mediates bax transl-ocation in nitric oxide-induced apoptosis inncurons[J]. J CellBio,1200 0,150(2):335-347.
[90]阮颖新,刘素雁,李春媚,等.单侧输尿管梗阻大鼠模型中p38MAPK表达与细胞凋亡.中国病理生理杂志,2008,24(4)：749-754.
[91]水华,丁国华.p38信号通路对单侧输尿管结扎大鼠RANTES的影响.中华急诊医学杂志,2006,15(8)：706-709
[92]张梅,唐嘉薇,李晓玫.1L-1β通过p38MAPK信号途径诱导肾小管细胞转 分化并影响其移行功能[J].中华医学杂志,2003.83(13)：1161-1165.
[93]Balwin A S.The NF-κB and IκB Proteins:new Discoveries and Insigh ts[J].Annu Rev I mmunol,1996,14:649-683.
[94]Auwardt R,Mudge SJ,Chen C,etal.Regulation of nuclear factor B by corticosteroidsinrat mesangial cells [J]. J Am Soc Nephrol,1998.9:1620-1628.
[95]张爱华,陈荣华,黄松明,等.阿霉素肾病大鼠肾组织中核因子-κB活化与肾小管间质损害的关系[J].南京医科大学学报,2001,21(1)：6-9.
[96]Whiteside ST Israel A.IB Proteins:structure, function and regulation [J].Semin Cancer B iol,1997,8:75-82.
[97]Bonizzi G,KarinM.The two NF-kappaB activation pathways and their role in innate and adaptive immunity Trends Immunol 2004;25:280-288
[98]Luo JL,Kamata H,Karin M. IK K/N F-kappaB signaling:balancing life and death-a new approach to cancer therapy,J Clin Invest 2005; 115:2625-2632
[99]LiZ W,Chu W,Hu Y,Delhase M,Deerinek T, Ellisman M,Johnson R,K arin M.The IKBeta subunit of IkappaB kinase(lKK)is essential for ucle ar factor kaPPaB activation and Prevention of apoptosis.J Exp Med 19 99; 189:1839-1845
[100]Seftleben U,Cao Y,Xiao G,Greten FR,Krahn G,Bonizzi G,Chen Y,Hu Y,Fong A,Sun SC,Karin M. Activation by IKKalPha of a second, evolutionary eonserved, NF-kaPPaB signaling pathway.Scienee 2001;293:1495-1499
[101]Xavicr RJ.et al.2000,Science,289:1483-1484.
[102]Karin M et al.2000,Semin 1mmunol,12:85-98.
[103]HinzM,Krappmann D,Eichten A, et al.NF-kappa B Function in Gro-wth C ontrol:Regul ati on of CyclinDl Expression and G0/G1-to-S-ph ase transition[J].Mol Cell Biol,1999,19(4):2690-2698.
[104]Gui jarroC. Central Role of the Transcription Factor Nuclear Factor Kappa-B in Mesangial Cell Production of Chemokines[J].Contrib Nephro-1,1997,120:210-218.
[105]Tergaonk ar V,Pando M,Vafa O.et al.p53 stabilization is decreased upon NF kappaB activation:a role for NfkappaB in acquisition of resistance to chemotherapy.Cancer Cell,2002,1(5):493-503.
[106]裘奇,刘志红.核因子-κB的分子生物学特性及其在细胞凋亡中的作用.肾脏病与透析肾移植杂志,1997,6(3)：246-248.
[107]FukudaK,Yoshitomi K,Yanagida T,etal.Quantification of TGF-β1mRNA along rat nephron in obstructive nephropathy.Am J Physiol Renal Physiol,2001,281(3):F513-F521.
[108]WangY, Rangan GK, et al. Induction of monocyte chemoattractan t protein-1 by albumin ismediated by nuclear factor kappaB in proximal tubule cells. J Am Soc Nephrol 1999,10(6):1204-13.
[109]Han H J,Oh Y J,Lee Y J.Effect of Albumin on 14C-al pha-Methy 1-D-G lu copyranoside Uptake in Primary Cultured Renal Proximal Tubule Cells:lnvolvement of PLC,M A PK,an d NF-κB [J].Cell Phy siol.2005,202(1): 246-254.
[110]Komiya T,Miura K.Tsulamoto J,et al.Possible Involvement of Nuclear Factor-kappa B Inhibition in the Renal Protective Efect of Oral Adsorbent AST-120 in a Rat Model of Chronic Renal Failure[J].Int J Mol Med,2004,13(1):133-138.
[111]Barnes P J, Karin M. Nuclear Factor-kappa B:a Pivotal Tran scrip-tion Factor in Chronic Inflammatory Diseases[J].N Engl J Med,1997,3 36(15):1066-1071
[112]GrossML, HankeW, KochA, et al. I ntraperi tonealp rotein injection in the axolot:the amphibian kidney as a novel model to study tubu-lointerstitial activation[J].Kidney Int,2002,62:51.
[113]KANETO H,MORRISSEY J.KLAHR S.Increased expression of TGF-β1 Mrna in the obstructed kidney of rats with unilateral ureteral ligati on[J].Kidney Int,1993,44(6):313-321.
[114]Klahr S, Morrissey J. Obstructive nephropathy and renal fibrosis [J] Am J Physiol Renal Physiol,2002,283(5):861-875
[115]Yang, Jun Wei, Liu You Hua-Blockage of tubular epithelial to my-ofibroblast transition by hepatocyte growth factorprevents renal intersti tial fibrosis [J] J Am Soc N ephrol.2002,13 (1):96-107.
[116]Qi W, Chen X, Poronnik P, et al. The renal cortical fibroblast inrenal tubulointerstitial fibrosis [J]. Int J Biochem Cell Biol.2006,38(I):I-5.
[117]Picard N, BaumO, Vogetseder A, et al. Origin of renal myofibro-blasts in the model of unilateral ureter obstruction in the rat [J]. His-tochem Cell Biol,2008,130(1):141-155.
[118]PakkanenO, HamalainenE, KivirikkoK, et, al.Aessmblyof Stable Human TyPe and IllCollagen Moleeules From Hydroxylatedre combinant Chains In the Yeast Piehia Pastoris[J].The Journal of Biological Chemistry,2003, 278(34):32478-32482.
[119]康丽华.胶原蛋白与肝纤维化[J].中国疗养医学.2006,15(6)：417-419
[120]孙柱,徐曼,邹万忠.肾小管间质纤维化中转化生长因子的表达特征.中华肾脏病杂志,2000,16：291
[121]Kaneto H,Ohtani H,Fukuzaki A,et al.Increased expression of TGF-β1 but not of its receptors contributes to human obstructive nephropat-hy. Kidney Int,1999,56(6):2137-46.
[122]Stambe C, Atkins R C,Tesch G H, et al.The Role of p38alpha Mitogen2 Activated Protein Kinase activa2tion in renal fibrosis[J]. J Am Soc Nephrol,2004,15 (2):370-379.
[123]Zhang Z,Cohen DM,et,al. NaCl but not urea activates p38 and JU N kinase in Mimed3 murine inner medullary cells.J Biochem,1996,271(6 Pt2):F 1234-F1238.
[124]Ge lei leteTJ,Mel oGC.GostaRS,etal.Rol eof yofibro blasts, mac rophages, transforming growth factor-beta endothelin, angiotensinll,an d fibronectin the progression of tubuloin-terstitial nephritis induced by gentamicin.J Nephrol,2002,15(6):633-642
[125]祝胜郎,余学清,娄宁,等P38MAPK在火鼠梗阻性肾病肾组织中的表达及可能作用[J].中国病理生理杂志,2004,20(4)：545-549.
[126]杨继红,郑法雷,吴华,等.他克莫司对转化生长因子-β诱导的肾小管上 皮细胞转分化的抑制作用及对核因子-活性的影响.肾脏病与透析肾移植杂志,2004,13(2)：124-128.
[127]干永钧,张敏鸥.痰瘀互结与肾内微型癥积[J].中国中两医结合肾病杂志,2003,4(1)：1
[128]Magnatri P Fishers J,Globus R K.Extrace llularmatrix remodeling by metallo proteinases and plasminogen activator.Kidney Int,1995,47(Suppl): 12.14
[129]盛丽,等.水蛭、地龙抗实验性小鼠肺纤维化作用的研究.中医研究,2006,19(2)：15-17
[130]陈洪,陆亚琴,刘顺英,等.地龙2号对大鼠肝纤维化TGF-β1.MMP-13及TIMP-1mRN A和白表达的影响[J]世界华大消化杂志,2004,12(10)：354-356.
[131]陈洪,陆亚琴,刘顺英,等.地龙2号对大鼠肝纤维化α-SMA、TGF-β1.MMP-13及TIMP-1蛋白表达的影响[J]胃肠病学和肝病学杂志,2005,14(2)：443-446
[132]陈洪,陆亚琴,刘顺英,等.地龙2号对肝纤维化模型大鼠肝星状细胞活化及TG-β1蛋白表达的影响[J].江苏中医药,2005,26(1)：50-52
[133]陆亚琴,等.地龙2号抑制大鼠肝纤维化的研究.胃肠病学和肝病学杂志,2004,13(3)：225-227
[134]陈洪,等.蚯蚓提取物对肝纤维化大鼠α-SMA、TGF-β1、uPA及PA1-1蛋白表达的影响.江苏医药,2005,31(6)：443-445
[135]马艳春,周波,孙许涛,等.MTT法检测地龙有效成分对肾小球系膜细胞增殖的影响.中医药信息,2010,27(1)：34-36
[136]薛痕,樊均明,陈亮,等.大鼠肾间质纤维化动物模型的实验研究.四川动物,2004,23(1)：16-20
[137]Strutz F.Transdifferentiation:a new concept in renal fibrogenesis. J Am Soc Nephrol,1994,5:819-822.
[138]张志新,黄迪,吴锋,等TGF-β1/p38MAPK通路对肾间质纤维化影响及抗纤灵冲剂干预机制的实验研究.中华中医药杂志,2011,2(2)：245-248
[139]O'Donnell MP.Renal tubulointerstitial fibrosis:new thoughs on its development and progression.Postgrad Med.2000,108:159-172.
[140]余学清,祝胜郎.娄宁,等.依那普利对梗阻性肾病大鼠肾组织p38MAPK丝裂素激活蛋白激酶活性的影响.中华肾脏病杂志,2004,20(3)：181-185
[141]Morrissey J, Klahr S. Transcription factor NF-kappaB regulation of renal fibrosis during ureteral obstruction. Semin Nephrol 1998,18(6): 603-11